BIO-THERA SOLUTIONS, LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.05 CNY | +1.97% |
|
+12.89% | -22.28% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bio-Thera Solutions, Ltd. is a China-based company mainly engaged in the research and development of innovative drugs and biosimilars. The Company is committed to the development of a new generation of antibody drugs to treat cancer, autoimmune diseases, cardiovascular diseases and other major diseases that endanger human life and health. The Company's main products include adalimumab BAT1406, bevacizumab BAT1706, BAT8001, tocilizumab BAT1806, batifaban BAT2094, BAT8003 and so on.
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
32.05
CNY
Average target price
54
CNY
Spread / Average Target
+68.49%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.28% | 1.83B | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- 688177 Stock
- News Bio-Thera Solutions, Ltd.
- Bio-Thera Solutions Grants Marketing Rights of Two Drugs to Latin American Company
